Human TNF‐α in transgenic mice induces differential changes in redox status and glutathione‐regulating enzymes
- 18 July 2002
- journal article
- Published by Wiley in The FASEB Journal
- Vol. 16 (11) , 1450-1452
- https://doi.org/10.1096/fj.01-0948fje
Abstract
Tumor necrosis factor α (TNF‐α) is a pleiotropic cytokine involved in several diseases. Various effects of TNF‐α are mediated by the induction of a cellular state consistent with oxidative stress. Glutathione (GSH) is a major redox‐buffer of eukaryotic cells and is important in the defense against oxidative stress. We hypothesized that persistent TNF‐α secretion could induce oxidative stress through modulation of GSH metabolism. This hypothesis was examined in a transgenic mouse model with low, persistent expression of human TNF‐α in the T cell compartment. Major findings were i) marked tissue‐specific changes in GSH redox status and GSH regulating enzymes, with the most pronounced changes in liver; ii) moderate changes in GSH metabolism and up‐regulation of GSH‐regulating enzymes were observed in lung and kidney from transgenic mice; and iii) liver, lung and kidney from transgenic mice had decreased levels of total glutathione, whereas splenic CD4+ and CD8+ T cells had a marked increase in oxidized glutathione as the major change.Oxidative stress induced by persistent low‐grade exposure to TNF‐α in transgenic mice appears to involve marked organ‐specific alterations in glutathione redox status and glutathioneregulating enzymes with the most pronounced changes in the liver. These mice constitute a useful model for immunodeficiency syndromes and chronic inflammatory diseases involving pathogenic interaction between TNF‐α and oxidative stress.Keywords
Funding Information
- Norges Forskningsråd
- Universitetet i Oslo
This publication has 63 references indexed in Scilit:
- Effects of hTNFα expression in T cells on haematopoiesis in transgenic miceEuropean Journal of Haematology, 2009
- β-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trialThe Lancet, 2001
- IL‐1‐ and TNF‐induced bone resorption is mediated by p38 mitogen activated protein kinase*Journal of Cellular Physiology, 2001
- Disruption of Redox Homeostasis in Tumor Necrosis Factor-Induced Apoptosis in a Murine Hepatocyte Cell LineThe American Journal of Pathology, 2000
- Molecular Mechanism of the Regulation of Glutathione Synthesis by Tumor Necrosis Factor-α and Dexamethasone in Human Alveolar Epithelial CellsJournal of Biological Chemistry, 1999
- Role of glutathione redox cycle in TNF-α-mediated endothelial cell dysfunctionAtherosclerosis, 1995
- Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluidsThe Lancet, 1991
- Regulation of T-cell activation and T-cell growth factor (TCGF) production by hydrogen peroxideCellular Immunology, 1987
- ASSOCIATION BETWEEN TUMOUR NECROSIS FACTOR IN SERUM AND FATAL OUTCOME IN PATIENTS WITH MENINGOCOCCAL DISEASEThe Lancet, 1987
- Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors.The Journal of Experimental Medicine, 1986